| abstract |
The disclosure relates to Azetidine-Substituted Quinoxaline-Type Piperidine Compounds of Formula (I): (R3 )b (R2)a (I) and pharmaceutically acceptable derivatives thereof wherein the R1 , R2, R3, Q, Y1, Z, A, B, a, and b are as defined herein, compositions comprising an effective amount of an Azetidine-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an Azetidine-Substituted Quinoxaline-Type Piperidine Compound. |